Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 11 Breast 4 Lymphoid 2 Genitourinary 2 Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Head & Neck 1 Gynecologic 1 Endocrine 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 581 Carboplatin 527 Cisplatin 355 Bevacizumab 256 pembrolizumab 226 Gemcitabine 157 liposomal doxorubicin 132 Topotecan 131 olaparib 129 Cyclophosphamide 126 Radiotherapy 118 Taxes 114 Docetaxel 95 Brachytherapy 94 Drug Therapy 90 niraparib 88 Doxorubicin 86 Surveys and Questionnaires 85 Magnetic Resonance Spectroscopy 80 Blood Specimen Collection 73 Nivolumab 71 Specimen Handling 70 Hyperthermic Intraperitoneal Chemotherapy 64 Biopsy 63 fludarabine 56 Filgrastim 53 Letrozole 50 Oxaliplatin 49 durvalumab 47 Immunoglobulin G 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Diffusion Tensor Imaging × Gynecologic × Clear all

NCT01060033 2017-04-14

MRI

Washington University School of Medicine

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡